NO942952L - 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike - Google Patents

11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike

Info

Publication number: NO942952L
Authority: NO; Norway
Prior art keywords: preparation; benzaldoxyn; aters; medicament containing; oestradiene
Prior art date: 1993-09-20

Application number

NO942952A

Other languages

English (en)

Other versions

NO942952D0 (no

NO304988B1 (no

Inventor

Gerd Schubert

Gunther Kaufmann

Lothar Sobeck

Michael Oettel

Walter Elger

Anatoli Kurischko

Original Assignee

Jenapharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-20

Filing date

1994-08-09

Publication date

1995-03-21

1994-08-09 Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh

1994-08-09 Publication of NO942952D0 publication Critical patent/NO942952D0/no

1995-03-21 Publication of NO942952L publication Critical patent/NO942952L/no

1999-03-15 Publication of NO304988B1 publication Critical patent/NO304988B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO942952A 1993-09-20 1994-08-09 11-benzaldoksim-17<beta>-metoksy-17<alfa>-metoksymetyl-°stradienderivater samt farmas°ytisk preparat inneholdende slike NO304988B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4332284A DE4332284C2 (de)	1993-09-20	1993-09-20	11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (3)

Publication Number	Publication Date
NO942952D0 NO942952D0 (no)	1994-08-09
NO942952L true NO942952L (no)	1995-03-21
NO304988B1 NO304988B1 (no)	1999-03-15

Family

ID=6498354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO942952A NO304988B1 (no)	1993-09-20	1994-08-09	11-benzaldoksim-17<beta>-metoksy-17<alfa>-metoksymetyl-°stradienderivater samt farmas°ytisk preparat inneholdende slike

Country Status (19)

Country	Link
EP (1)	EP0648779B1 (no)
JP (1)	JP2696672B2 (no)
KR (1)	KR100190775B1 (no)
AT (1)	ATE149513T1 (no)
AU (1)	AU682373B2 (no)
CA (1)	CA2130515C (no)
CZ (1)	CZ289801B6 (no)
DE (2)	DE4332284C2 (no)
DK (1)	DK0648779T3 (no)
ES (1)	ES2102144T3 (no)
FI (1)	FI112948B (no)
GR (1)	GR3023644T3 (no)
HU (1)	HU219399B (no)
NO (1)	NO304988B1 (no)
NZ (1)	NZ264228A (no)
PL (1)	PL179460B1 (no)
RU (1)	RU2130944C1 (no)
SK (1)	SK280315B6 (no)
UA (1)	UA39101C2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332283A1 (de) *	1993-09-20	1995-04-13	Jenapharm Gmbh	Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) *	1994-09-20	1996-11-19	Jenapharm Gmbh	11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
DE19745085A1 (de) *	1997-10-11	1999-04-15	Jenapharm Gmbh	11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE19809845A1 (de) *	1998-03-03	1999-09-09	Jenapharm Gmbh	S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE19906152B4 (de)	1999-02-10	2005-02-10	Jenapharm Gmbh & Co. Kg	Wirkstoffhaltige Laminate für Transdermalsysteme
IL148415A0 (en) *	1999-08-31	2002-09-12	Jenapharm Gmbh	Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
EP1605924B1 (en) *	1999-08-31	2008-11-05	Bayer Schering Pharma Aktiengesellschaft	Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
ATE375160T1 (de)	1999-08-31	2007-10-15	Bayer Schering Pharma Ag	Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
US7629334B1 (en) *	1999-08-31	2009-12-08	Bayer Schering Pharma Aktiengesellschaft	Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
DE19961219A1 (de) *	1999-12-15	2001-07-19	Jenapharm Gmbh	11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10056677A1 (de)	2000-11-10	2002-05-16	Jenapharm Gmbh	Verfahren zur Herstellung von 4-(17a-Alkoxymethyl-17ß-substituierten-3-oxoestra-4,9-dien-11ß-yl)benzaldehyd-(1E)-oxim-Derivaten
DE10056676A1 (de) *	2000-11-10	2002-05-16	Jenapharm Gmbh	Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
EP1285927A3 (de) *	2001-08-16	2005-06-29	Schering Aktiengesellschaft	Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10221034A1 (de)	2002-05-03	2003-11-20	Schering Ag	17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE10236405A1 (de)	2002-08-02	2004-02-19	Schering Ag	Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
AU2003255355A1 (en) *	2002-08-02	2004-02-25	Schering Aktiengesellschaft	Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
DE102005059222B4 (de) *	2005-12-08	2007-10-11	Bayer Schering Pharma Ag	11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen
LT2078032T (lt)	2006-10-24	2017-11-10	Repros Therapeutics Inc.	Kompozicijos ir būdai, skirti gimdos gleivinės proliferacijos slopinimui
TWI539953B (zh)	2008-04-28	2016-07-01	瑞波若斯治療學公司	用於治療乳癌之組成物和方法
CN102906103A (zh)	2010-03-22	2013-01-30	利普生物药剂公司	用于抗孕酮的非毒性递送的组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU580843B2 (en) *	1985-02-07	1989-02-02	Schering Aktiengesellschaft	11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3504421A1 (de) *	1985-02-07	1986-08-07	Schering AG, 1000 Berlin und 4709 Bergkamen	Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
EP0411733B1 (de) *	1989-08-04	1998-10-21	Schering Aktiengesellschaft	11 Beta-Aryl-gona-4,9-dien-3-one
DE4332283A1 (de) *	1993-09-20	1995-04-13	Jenapharm Gmbh	Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

1993
- 1993-09-20 DE DE4332284A patent/DE4332284C2/de not_active Expired - Lifetime
1994
- 1994-07-07 DE DE59401919T patent/DE59401919D1/de not_active Expired - Fee Related
- 1994-07-07 DK DK94250179.2T patent/DK0648779T3/da active
- 1994-07-07 EP EP94250179A patent/EP0648779B1/de not_active Expired - Lifetime
- 1994-07-07 ES ES94250179T patent/ES2102144T3/es not_active Expired - Lifetime
- 1994-07-07 AT AT94250179T patent/ATE149513T1/de not_active IP Right Cessation
- 1994-08-09 FI FI943688A patent/FI112948B/fi active
- 1994-08-09 NO NO942952A patent/NO304988B1/no not_active IP Right Cessation
- 1994-08-10 SK SK958-94A patent/SK280315B6/sk not_active IP Right Cessation
- 1994-08-11 RU RU94029667/04A patent/RU2130944C1/ru not_active IP Right Cessation
- 1994-08-12 NZ NZ264228A patent/NZ264228A/en not_active IP Right Cessation
- 1994-08-15 CZ CZ19941969A patent/CZ289801B6/cs not_active IP Right Cessation
- 1994-08-18 AU AU70351/94A patent/AU682373B2/en not_active Ceased
- 1994-08-19 CA CA002130515A patent/CA2130515C/en not_active Expired - Lifetime
- 1994-08-19 UA UA94085724A patent/UA39101C2/uk unknown
- 1994-08-25 KR KR1019940020993A patent/KR100190775B1/ko not_active IP Right Cessation
- 1994-09-19 PL PL94305091A patent/PL179460B1/pl not_active IP Right Cessation
- 1994-09-19 HU HU9402695A patent/HU219399B/hu not_active IP Right Cessation
- 1994-09-20 JP JP6224380A patent/JP2696672B2/ja not_active Expired - Fee Related
1997
- 1997-05-30 GR GR970401290T patent/GR3023644T3/el unknown

Also Published As

Publication number	Publication date
HU219399B (hu)	2001-04-28
EP0648779A3 (de)	1995-08-09
JPH07149790A (ja)	1995-06-13
CZ196994A3 (en)	1995-04-12
PL179460B1 (pl)	2000-09-29
NO942952D0 (no)	1994-08-09
ATE149513T1 (de)	1997-03-15
AU682373B2 (en)	1997-10-02
HUT68315A (en)	1995-06-28
UA39101C2 (uk)	2001-06-15
EP0648779A2 (de)	1995-04-19
ES2102144T3 (es)	1997-07-16
FI943688A0 (fi)	1994-08-09
FI112948B (fi)	2004-02-13
FI943688A (fi)	1995-03-21
GR3023644T3 (en)	1997-08-29
KR950008531A (ko)	1995-04-19
JP2696672B2 (ja)	1998-01-14
DE4332284A1 (de)	1995-03-23
DE59401919D1 (de)	1997-04-10
NZ264228A (en)	1995-04-27
CA2130515A1 (en)	1995-03-21
SK95894A3 (en)	1995-04-12
NO304988B1 (no)	1999-03-15
KR100190775B1 (ko)	1999-06-01
PL305091A1 (en)	1995-04-03
RU2130944C1 (ru)	1999-05-27
SK280315B6 (sk)	1999-11-08
DE4332284C2 (de)	1997-05-28
AU7035194A (en)	1995-03-30
CA2130515C (en)	2001-07-17
EP0648779B1 (de)	1997-03-05
HU9402695D0 (en)	1994-11-28
RU94029667A (ru)	1996-06-27
DK0648779T3 (da)	1997-09-15
CZ289801B6 (cs)	2002-04-17

Publication	Publication Date	Title
NO942953D0 (no)	1994-08-09	11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
NO942952L (no)	1995-03-21	11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
ES2081187T3 (es)	1996-02-16	Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE170510T1 (de)	1998-09-15	3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
AU4616893A (en)	1994-03-17	New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
ES2111871T3 (es)	1998-03-16	Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9400165A (es)	1994-07-29	Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
DK0571243T3 (da)	1995-12-04	Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse
ES2110030T3 (es)	1998-02-01	Nuevos derivados de 17-hidroxiiminometil-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.
DE69412612D1 (de)	1998-09-24	Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
ES2076054T3 (es)	1995-10-16	Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2123038T3 (es)	1999-01-01	Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date	Code	Title	Description
2011-04-04	MM1K	Lapsed by not paying the annual fees